Quarter Financials

Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC (ADAP)

$4.82
0.02 (+0.42%)
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in millions

Retained Earning Schedule

Year 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q3
Net Income -30-28-29-39-41-27-365-43-21-1
Dividend Paid -----------
Retained Earnings -514-484-456-426-387-346-318-282-288-244-204

PPE Schedule

Year 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q3
Capital Expenditure -1-0-1-0-1-1-0-1-1-2-2
Net PPE 4648525255603638404140

Intangible and Goodwill Schedule

Year 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q3
New Purchases -13-12-21-42-75-4-12-3-8--200
Intangible and Goodwill -----------